Immunization of mice with one or two doses of this vaccine candidate adjuvanted with Alhydrogel® induced serum antibodies with complete TB activity persisting through the six-month study period [32], supporting the evaluation of Pfs25-CP VLP as a potential malaria TBV candidate. Here, CP is linked to malaria.